COX

环氧合酶 (COX) 的正式名称是前列腺素内过氧化物合酶 (PTGS),它是一种负责形成重要生物介质前列腺素类物质的酶,包括前列腺素、前列环素和血栓素。通过药物抑制 COX 可以缓解炎症和疼痛症状。抑制环氧合酶活性的药物(如阿司匹林)已经面世约 100 年。已鉴定出两种环氧合酶同工酶,分别称为 COX-1 和 COX-2。在许多情况下,COX-1 酶是组成性产生的(即胃粘膜),而 COX-2 是可诱导的(即炎症部位)。非甾体抗炎药 (NSAID),如阿司匹林和布洛芬,通过抑制 COX 发挥作用。主要的 COX 抑制剂是非甾体抗炎药 (NSAID)。

Cyclooxygenase (COX), officially known as prostaglandin-endoperoxide synthase (PTGS), is an enzyme that is responsible for formation of important biological mediators called prostanoids, including prostaglandins, prostacyclin and thromboxane. Pharmacological inhibition of COX can provide relief from the symptoms of inflammation and pain. Drugs, like Aspirin, that inhibit cyclooxygenase activity have been available to the public for about 100 years. Two cyclooxygenase isoforms have been identified and are referred to as COX-1 and COX-2. Under many circumstances the COX-1 enzyme is produced constitutively (i.e., gastric mucosa) whereas COX-2 is inducible (i.e., sites of inflammation). Non-steroidal anti-inflammatory drugs (NSAID), such as aspirin and ibuprofen, exert their effects through inhibition of COX. The main COX inhibitors are the non-steroidal anti-inflammatory drugs (NSAIDs).

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
Sudoxicam
舒多昔康

Sudoxicam 是一种烯醇-羧酰胺类的非甾体抗炎剂 (NSAID),作为可逆的口服活性 COX 拮抗剂,具有有效的抗炎、抗浮肿和退热作用。

34042-85-8
Antagonist
99.96%
舒多昔康
Sudoxicam (Standard)
舒多昔康 (标准品)

Sudoxicam (Standard) 是 Sudoxicam 的分析标准品,用于研究及分析应用;Sudoxicam 是一种可逆的口服活性 COX 拮抗剂,属于烯醇-羧酰胺类非甾体抗炎剂 (NSAID),具有有效的抗炎、抗浮肿和退热作用。

34042-85-8
Antagonist
98%
舒多昔康 (标准品)

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础